Z

Zhejiang Jiuzhou Pharmaceutical Co Ltd
SSE:603456

Watchlist Manager
Zhejiang Jiuzhou Pharmaceutical Co Ltd
SSE:603456
Watchlist
Price: 15.57 CNY -0.19% Market Closed
Market Cap: 14B CNY
Have any thoughts about
Zhejiang Jiuzhou Pharmaceutical Co Ltd?
Write Note

Zhejiang Jiuzhou Pharmaceutical Co Ltd
Other Current Assets

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Zhejiang Jiuzhou Pharmaceutical Co Ltd
Other Current Assets Peer Comparison

Comparables:
H
3692
600436
600276
000538
S
688506

Competitive Other Current Assets Analysis
Latest Figures & CAGR of Competitors

Company Other Current Assets CAGR 3Y CAGR 5Y CAGR 10Y
Z
Zhejiang Jiuzhou Pharmaceutical Co Ltd
SSE:603456
Other Current Assets
ÂĄ179.4m
CAGR 3-Years
-4%
CAGR 5-Years
7%
CAGR 10-Years
37%
H
Hansoh Pharmaceutical Group Company Ltd
HKEX:3692
Other Current Assets
ÂĄ129.8m
CAGR 3-Years
30%
CAGR 5-Years
28%
CAGR 10-Years
N/A
Zhangzhou Pientzehuang Pharmaceutical Co Ltd
SSE:600436
Other Current Assets
ÂĄ357.3m
CAGR 3-Years
-54%
CAGR 5-Years
-7%
CAGR 10-Years
24%
Jiangsu Hengrui Pharmaceuticals Co Ltd
SSE:600276
Other Current Assets
ÂĄ1.8B
CAGR 3-Years
19%
CAGR 5-Years
17%
CAGR 10-Years
25%
Yunnan Baiyao Group Co Ltd
SZSE:000538
Other Current Assets
ÂĄ1B
CAGR 3-Years
-34%
CAGR 5-Years
5%
CAGR 10-Years
10%
S
Sichuan Biokin Pharmaceutical Co Ltd
SSE:688506
Other Current Assets
ÂĄ70.3m
CAGR 3-Years
58%
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Zhejiang Jiuzhou Pharmaceutical Co Ltd's Other Current Assets?
Other Current Assets
179.4m CNY

Based on the financial report for Jun 30, 2024, Zhejiang Jiuzhou Pharmaceutical Co Ltd's Other Current Assets amounts to 179.4m CNY.

What is Zhejiang Jiuzhou Pharmaceutical Co Ltd's Other Current Assets growth rate?
Other Current Assets CAGR 10Y
37%

Over the last year, the Other Current Assets growth was -29%. The average annual Other Current Assets growth rates for Zhejiang Jiuzhou Pharmaceutical Co Ltd have been -4% over the past three years , 7% over the past five years , and 37% over the past ten years .

Back to Top